Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
Curr Opin Urol
; 28(5): 461-468, 2018 09.
Article
in En
| MEDLINE
| ID: mdl-29979235
ABSTRACT
PURPOSE OF REVIEW Examine and discuss indications, technique, and outcomes for robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer. RECENT FINDINGS:
Open RPLND has been the longstanding standard of care for both primary and post chemotherapy RPLND. Recently, robotic RPLND has been an attractive option with the intent of reducing the morbidity associated with open surgery while providing identical oncologic efficacy. Naysayers of robotic RPLND suggest it is often inappropriately used as a staging procedure and consequently can compromise oncologic efficacy.SUMMARY:
Robotic RPLND is being evaluated as a therapeutic equivalent to open RPLND. On the basis of limited published data with modest follow-up from experienced centers, robotic RPLND appears to provide effective staging and therapeutic data mirroring that of open surgery.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Retroperitoneal Space
/
Testicular Neoplasms
/
Seminoma
/
Neoplasms, Germ Cell and Embryonal
/
Robotic Surgical Procedures
/
Lymph Node Excision
Limits:
Humans
/
Male
Language:
En
Journal:
Curr Opin Urol
Journal subject:
UROLOGIA
Year:
2018
Document type:
Article